Results 21 to 30 of about 107,657 (326)
Rationale: Current first-line treatments for stress-related disorders such as Major Depressive Disorder (MDD) act on monoaminergic systems and take weeks to achieve a therapeutic effect with poor response and low remission rates.
Sean C. Piantadosi +15 more
doaj +2 more sources
Glutamatergic dysfunction has been implicated in psychiatric disorders such as schizophrenia. The stimulation of metabotropic glutamate (mGlu) 2 receptor has been shown to be effective in a number of animal models of schizophrenia.
Hirohiko Hikichi +10 more
doaj +2 more sources
MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate
Douglas C Beshore +2 more
exaly +2 more sources
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators
Positive allosteric modulators (PAMs), negative allosteric modulators (NAMs), silent agonists, allosteric activating PAMs and neutral or silent allosteric modulators are compounds capable of modulating the nicotinic receptor by interacting at allosteric ...
Dina Manetti +6 more
doaj +1 more source
The allosterically modulated FFAR2 is transactivated by signals generated by other neutrophil GPCRs.
Positive allosteric modulators for free fatty acid receptor 2 (FFAR2/GPR43), that affect receptor function through binding to two distinct allosteric binding sites, were used to determine the correlation between the responses induced in neutrophils by ...
Simon Lind +3 more
doaj +2 more sources
Prospects for the use of allosteric drugs in real-world clinical practice
While the clinical validity of the use of allosteric regulation is known, scientists are working on the discovery of new methods for the development of allosteric drugs that can modulate the functions of enzymes, depending on the desired therapeutic ...
I. R. Svechkareva, A. S. Kolbin
doaj +1 more source
Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor [PDF]
μ-Opioid receptors are among the most studied G protein-coupled receptors because of the therapeutic value of agonists, such as morphine, that are used to treat chronic pain. However, these drugs have significant side effects, such as respiratory suppression, constipation, allodynia, tolerance, and dependence, as well as abuse potential.
Neil T, Burford +7 more
openaire +2 more sources
Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
Activation of G protein-coupled receptors (GPCRs) is an allosteric process. It involves conformational coupling between the orthosteric ligand binding site and the G protein binding site. Factors that bind at non-cognate ligand binding sites to alter the
Brandon Wey-Hung Liauw +5 more
doaj +1 more source
Among β-blockers that are clinically prescribed for heart failure, carvedilol is a first-choice agent with unique pharmacological properties. Carvedilol is distinct from other β-blockers in its ability to elicit β-arrestin–biased agonism, which has been ...
Biswaranjan Pani +9 more
semanticscholar +1 more source
α-conotoxins are 13–19 amino acid toxin peptides that bind various nicotinic acetylcholine receptor (nAChR) subtypes. α-conotoxin Mr1.7c (MrIC) is a 17 amino acid peptide that targets α7 nAChR.
Alican Gulsevin +6 more
doaj +1 more source

